Altesa Biosciences

Protecting Lungs. Improving Lives.

Altesa Biosciences is headquartered in College Park, United States, lists 1–10 employees, and has $114.0M in recorded funding across 3 rounds.

Employees
1–10
Business Model
B2B
Total Funding
$114.0M
Last Round
$75.0M Series BFeb 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Altesa BioSciences is a clinical-stage pharmaceutical company focused on developing antiviral therapies to protect people with chronic lung diseases from life-threatening respiratory virus infections. The company's primary program targets rhinovirus — the most common respiratory pathogen and the leading trigger of acute exacerbations in COPD and asthma patients — with an oral antiviral medicine (vapendavir) intended to prevent hospitalization and long-term lung function decline. Altesa's pipeline addresses a significant unmet need, as COPD affects 18.6 million Americans and generates an estimated $6.24 trillion in direct US medical costs between 2025 and 2050.

Summary

Altesa Biosciences is a Biotech company based in College Park, United States. It lists 1–10 employees. It has raised $114.0M in total across 3 rounds, most recently a $75.0M Series B round in Feb 2026. Investors include Forbion Capital Partners, Pitango Growth and Sanofi Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2026
$75.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Altesa Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/altesa-biosciences"><img src="https://indexed.vc/api/badge/company/altesa-biosciences" alt="Altesa Biosciences on Indexed.vc" width="260" height="76" /></a>